Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A O MARTINS

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Ebiomedicine|February 13, 2016
Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityKaren A O Martins, Christopher L Cooper, Sabrina M Stronsky, et al.
Ear, Nose, & Throat Journal|October 18, 2019
Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell CarcinomaMichelle Palmieri, Dmitry J S Sarmento, André P Falcão, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Frequency of Chronic Joint Pain Following Chikungunya Virus Infection: A Colombian Cohort StudyAileen Y Chang, Liliana Encinales, Alexandra Porras, et al.
Clinical and Experimental Rheumatology|October 3, 2022
Primary dental care treatment in primary Sjögren's syndrome: a possible role in improving salivary flow rateVictor A O Martins, Tamires F Floriano, Elaine P Leon, et al.
Clinics (Sao Paulo, Brazil)|December 18, 2022
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster doseRosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial FluidAileen Y Chang, Karen A O Martins, Liliana Encinales, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Ebiomedicine|February 13, 2016
Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityKaren A O Martins, Christopher L Cooper, Sabrina M Stronsky, et al.
Ear, Nose, & Throat Journal|October 18, 2019
Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell CarcinomaMichelle Palmieri, Dmitry J S Sarmento, André P Falcão, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Frequency of Chronic Joint Pain Following Chikungunya Virus Infection: A Colombian Cohort StudyAileen Y Chang, Liliana Encinales, Alexandra Porras, et al.
Clinical and Experimental Rheumatology|October 3, 2022
Primary dental care treatment in primary Sjögren's syndrome: a possible role in improving salivary flow rateVictor A O Martins, Tamires F Floriano, Elaine P Leon, et al.
Clinics (Sao Paulo, Brazil)|December 18, 2022
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster doseRosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial FluidAileen Y Chang, Karen A O Martins, Liliana Encinales, et al.
Nature Medicine|July 31, 2021
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trialAna C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Pageof 2